What is STVN's P/E ratio?

STEVANATO GROUP SPA (STVN) currently trades at a P/E ratio of 39.13.

STEVANATO GROUP SPA reports a Return on Equity (ROE) of 9.21%.

What is STVN's dividend yield?

STEVANATO GROUP SPA offers a dividend yield of 0.00%.

What is STVN's Quality Score?

Our AI rates STVN's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy STVN?

Our AI Timing Score for STVN is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does STVN belong to?

STEVANATO GROUP SPA is classified under the Healthcare >> Medical Instruments & Supplies sector on the NYSE exchange

STVN (NYSE) Stock Analysis | STEVANATO GROUP SPA

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

STVN AI Analysis Summary

Our AI summary for STVN: STEVANATO GROUP SPA (NYSE), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 39.13, ROE of 9.21%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

STVN

STEVANATO GROUP SPA

USD 19.85

-0.35 (-1.73%) Day Change

Watchlist Portfolio Compare Chart

39.13

P/E

0.29

D/E

9.2%

ROE

5.5%

ROA

0.00%

Div Yield

-20.70

PEG

STEVANATO GROUP SPA
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 19.85 Price -0.35 (-1.73%) Day Change	NEWS SCORE: 99

STVN, the overall quality is not quite good ( Quality = 54) but the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

44%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	2141
Magic Formula Rank by ROE	2141
Magic Formula Rank by ROIC	2162
Price	19.85
PBV / Sector	3.60 / 3.37
Earning Per Share	0.51

PE / Sector	39.13 / 44.25
PEG or PE/Growth / Sector	-20.70 / -1.35
Average 1M Daily Value	5.29 M GREAT
Average 1W Daily Value	6.35 M

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	11.75 / 82.17
NPM Average (%) / Sector	12.43 / 28.91 GOOD
NPM Change Average (%) / Sector	-4.49 / 208.28
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	5.46 / 7.70
ROA Average (%) / Sector	6.29 / -22.17
ROA Change Average (%) / Sector	-9.67 / 105.15
ROE (%) / Sector	9.21 / 10.10
ROE Average (%) / Sector	10.77 / 392.40
ROE Change Average (%) / Sector	-8.87 / 109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

41%

Dividend (%) / Sector	N/A / 0.99
Dividend Average (%) / Sector	0.27 / 1.43
Dividend Change Average (%) / Sector	3.64 / 11.29

Registration Details

Analyze Date	2026-08-01 08:00:32
Symbol	STVN
Name	STEVANATO GROUP SPA
Sector	Healthcare >> Medical Instruments & Supplies
Market	NYSE
Listed Shares	49.71 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	5,514.67 / 16,159.14

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Via Molinella 17, Piombino Dese, PD, Italy, 35017

Phone: 39 04 99 31 811

Website: https://www.stevanatogroup.com

Employees: 6,010

Sector: Healthcare >> Medical Instruments & Supplies

Description: Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.